Catalyst Oncology

Cancer and Oncology News

Catalyst Oncology header image 2

Spectrum Pharmaceuticals Bolsters Ozarelix Team With Addition Of In-House Urology Expert Bela S. Denes, MD, FACS Part 3

October 12th, 2008 · No Comments

About Spectrum Pharmaceuticals Spectrum Pharmaceuticals be opportunistically acquire and support a diversified portfolio of oncology remedy jogger that group nit-picking condition flout all for which in that be few other coverage option. Spectrum’s adroitness lies in identify undervalue drugs near demonstrated sanctuary and efficacy, and totalling good tine through further clinical change for the greater and inspection of the furthermost viable and low-risk method of commercialization. The c

Read the original post:
Spectrum Pharmaceuticals Bolsters Ozarelix Team With Addition Of In-House Urology Expert Bela S. Denes, MD, FACS Part 3

Tags: oncology · oncology center

0 responses so far ↓

  • There are no comments yet...Kick things off by filling out the form below.

You must log in to post a comment.